![Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. - Abstract - Europe PMC Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3378255/bin/cn-2011-00128x_0006.jpg)
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. - Abstract - Europe PMC
![Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging | ACS Chemical Neuroscience Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.8b00293/asset/images/large/cn-2018-00293f_0001.jpeg)
Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging | ACS Chemical Neuroscience
![Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update](https://www.globaldata.com/store/wp-content/uploads/sites/2/2022/04/Hyperalgesia-pipeline-drugs-market-by-targets.png)
Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
![Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging | ACS Chemical Neuroscience Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.8b00293/asset/images/large/cn-2018-00293f_0004.jpeg)
Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging | ACS Chemical Neuroscience
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g004.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Agonist-Induced Diuresis: Evidence for Stereoselectivity, Strain Differences, Independence of Hydration Variables and a Re
![Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling](https://www.science.org/cms/10.1126/scisignal.aai8441/asset/af19b0d1-3407-4f21-8f6d-9bcb1eddc0cd/assets/graphic/9_ra117_f2.jpeg)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
![Site of Opioid Action in the Human Brain: Mu and Kappa Agonists' Subjective and Cerebral Blood Flow Effects | American Journal of Psychiatry Site of Opioid Action in the Human Brain: Mu and Kappa Agonists' Subjective and Cerebral Blood Flow Effects | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.155.4.470/asset/images/medium/a95f2.jpeg)